羚锐制药：上半年净利润4.74亿元，同比增长14.85%

Core Insights - The company reported a revenue of 2.099 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.14% [1] - The net profit attributable to shareholders reached 474 million yuan, marking a year-on-year increase of 14.85% [1] - The basic earnings per share stood at 0.836 yuan [1] Financial Performance - Revenue: 2.099 billion yuan, up 10.14% year-on-year [1] - Net Profit: 474 million yuan, up 14.85% year-on-year [1] - Earnings per Share: 0.836 yuan [1]